chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe Night Sweats Problems; can't Sleep more than 2-hours; Vagina Juices (Running Down My Legs); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78-year-old female patient received bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NIGHT SWEATS (non-serious), outcome "not recovered", described as "Severe Night Sweats Problems"; INSOMNIA (non-serious), outcome "unknown", described as "can't Sleep more than 2-hours"; VAGINAL DISCHARGE (non-serious), outcome "unknown", described as "Vagina Juices (Running Down My Legs)". The events "severe night sweats problems", "can't sleep more than 2-hours" and "vagina juices (running down my legs)" required physician office visit. Therapeutic measures were taken as a result of night sweats.  Additional Information: From the first 2019 Pfizer Vaccine (as reported, possible discrepant), patient started having severe night sweats problems. She doesn't have hot flashes just night sweats. She can't sleep more than 2-hours and she wakes up sweating all over, including her hair (like she was taking a shower) and vagina juices (running down my legs) and patient is 78-years old. The patient immediately called her gynecologist and primary care physician and they have been prescribing several different medications for hot flashes and night sweats. Nothing works. Patient asks for help.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Received 2nd shot 7 days early.  No known adverse effect to the patient.
a potential solution to the treatment of Canker Sores; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 84-year-old patient received BNT162b2 (BNT162B2), on 01Feb2021 as dose 1, single (Lot number: EL1283) for covid-19 immunisation. The patient's relevant medical history included: "Canker sores" (ongoing), notes: Sores in my mouth and on my tongue on a constant basis. This began as young as 4 years old. The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious) with onset 2021, outcome "unknown", described as "a potential solution to the treatment of Canker Sores". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient was examined and treated by several Dentist for Canker Sores. There were times the Dentist told patient and patients parents that I had as many as 21 Canker Sores with some of them as large as a Dime. They could never eliminate them. Through patients adult life this continued and caused extreme discomfort. The patient always have had at least 4 to 5 Canker Sores in mouth.  Follow-up attempts are completed. No further information is expected.
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Rash on back, upper and lower extremities, face, buttocks.  Treatment : Prednisone 10mg,  Alclometasone cream 0.05%, Triamcinolone cream 0.1% Improved
Headaches, started 2 hours after receiving shot, lasted 1 1/2 days Fatigue, ongoing since day after shot. Can't walk far Fever, nausea & vomiting, indigestion starting 2 days after shot. Ongoing but heartbeat is lowering in day 5 of symptoms Lack of appetite, likely hand in hand with fever, ongoing since fever started sore muscles not limited to injection shot (sides, thighs, chest, neck) lasting 3 days after initial symptoms arose sore throat, at its worst day 1-3 of initial symptoms.could not speak due to severity day 2. short term loss of taste except for sweet flavors, day 4. Taste returned day 5 of symptoms. Congestion, appeared day 3 of symptoms, ongoing Pressure buildup/ears popping, day 4 of symptoms and ongoing
4x5cm indurated erythematous tender lesion: redness/warmth/swelling
Information has been received from a physician concerning a 15 year old female with eczema and no drug allergies, who approximately "three weeks ago" on 21-AUG-2007 was vaccinated intramuscularly with a 0.5mL dose of GARDASIL. There was no concomitant medication. Subsequently, approximately "three weeks ago" on 21-AUG-2007 the patient experienced an eczema flair up from head to toe. The patient went to the office and was treated with an injection of cortisone for the symptoms. The patient went to the office. At the time of the report, the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Patient was given pediarix vaccine instead of pentacel. I had misread the list of vaccines due for the patient.
Breakthrough case admission after 3 vaccines Pfizer 3/20/21 lot# EP7534;  Pfizer 4/10/21 lot# EW0161;  Pfizer 11/13/21 lot# FH8030
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. On 13-AUG-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) lot # L013068 with exp. 14-APR-2017, (dose and route were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
24 hours after the shot, I developed swelling lymph nodes to my neck. I was experiencing muscle aches. I had a temp of 100 degrees. The swelling on my neck was visible. The swelling was under my armpits. The injection sight was red and swelling as well. The redness wrapped around my arm and started swelling and lumping pain. I went to the doctor on the 31st of January. I was diagnosed with cellulitis related to the injection. I was placed on antibiotics.
Patient reported to have developed redness and swelling at site of injection accompanied by intense itchiness. This can be a common reaction to the vaccine but the patient does not agree.
Limited breathing ability, could only take really short breathes and it felt extremely hard to breath at all. Also because extremely overheated and red. Lasted about 2 minutes. Was fanned and drank water and then started to feel better.
Swelling at the site and it spread to a larger area on my arm, fever, weakness, pain, throbbing shooting pain.
weakness in arm; Whole arm was affected,including shoulder and elbow soreness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (weakness in arm) and MYALGIA (Whole arm was affected,including shoulder and elbow soreness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, the patient experienced MUSCULAR WEAKNESS (weakness in arm) and MYALGIA (Whole arm was affected,including shoulder and elbow soreness). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, MUSCULAR WEAKNESS (weakness in arm) and MYALGIA (Whole arm was affected,including shoulder and elbow soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant products were reported.
pt recv vax 930AM & inconsolable crying from 2-9PM same day;afeb;APAP;
Pericarditis; booster; Dose 1: Moderna, Dose 2: Moderna; Dose 1: Moderna, Dose 2: Moderna; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 02Dec2021 14:30 (Batch/Lot number: unknown) at the age of 45 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ALLEGRA. Vaccination history included: Moderna (Dose 2, Single,, Dose administration time: 08:30 , Dose brand: Moderna), administration date: 08Apr2021, when the patient was 44 years old, for Covid-19 Immunization; Moderna (Dose 1, Single, Dose administration time: 12:00, Dose brand: Moderna), administration date: Mar2021, when the patient was 44 years old, for Covid-19 Immunization. The following information was reported: PERICARDITIS (hospitalization, medically significant) with onset 03Dec2021 02:00, outcome "recovering", described as "Pericarditis"; IMMUNISATION (non-serious) with onset 02Dec2021 14:30, outcome "unknown", described as "booster"; OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 02Dec2021 14:30, outcome "unknown" and all described as "Dose 1: Moderna, Dose 2: Moderna". The patient was hospitalized for pericarditis (hospitalization duration: 1 day(s)). The event "pericarditis" was evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Dec2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of pericarditis.  Clinical course: The patient has not experienced Covid-19 prior to vaccination. The patient has tested for Covid-19 post vaccination. No known allergies were reported. The patient did not receive other vaccine in four weeks. The patient received NSAIDs as treatment for adverse event. The patient had not covid prior vaccination. The patient was covid tested post vaccination.   The lot number for bnt162b2 was not provided and will be requested during follow up.
High fever of 103.6 degrees Fahrenheit, inconsolable crying and screaming, large lump under injection sites.
Red, warm, swollen, painful upper arm where injection done.  Still red and warm four days later.  Sore to the touch.
please note pharmacy did not give manufacturer of FLU so what i selected might be inaccurate .  THE ADVERSE REACTION WAS TO COVID  5 shots prior version zero reaction this new formula massive reaction : 1) threw up three times  2) created major muscle spasms in my lower back & front pelvic area was in horrific pain did not sleep for two days missed family reunion . 3) pee changed color to orange 4) just started to feel normal 10.1.2023   I emailed my doctor (did not go in person ) CALLED CDC for help and called pharmacy for help
Location where flu vaccine was administered still hurts two weeks after administration. Painful to exert deltoid muscle.
Patient has swelling in her right arm and redness and warmth form elbow to arm pit and had tingling in fingers and fingers cold.  States thought tongue might be swelling.
Urticarial rash on upper trunk & face. 10 X 10cm raised, indurated area @ inject site /w a ring around it.  Allergic to Amoxicillin & some environmental substances. 5th DTP, no previous problems.
told clinic this would be his first dose/ actually had first dose just two weeks prior; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 27-Jun-2022 Reporters comment: Nurse reported patient came in and received Shingrix vaccine. He told clinic this would be his first dose, however after it was administered, they realized he actually had first dose just two weeks prior. Reporter did not want to provide any further details. Reporter does not want to be contacted for follow-up. Nurse declined to provide any information additional information. Did not consent to follow-up. Additional Supportive Information: The patient received two doses of Shingrix, 2 weeks apart, which led to shortening of vaccination schedule.
ZOSTAVAX: 6-1-14; reaction started 6-3-14. Redness at injection site. Warm to touch at site. Area of reaction across deltoid region. TYLENOL/IBU OTC recommend.
Headache pain scale of 1-10, it was a 7. Tylenol did not relieve pain. Had to leave work early. With rest, it got better the next day. Estimated gestation that day, 1/13/2021, was 27 weeks and 6 days. Estimated date of delivery will be 04/08/2021. No expected complications with fetus.
knocked out for an entire day/out of it; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (knocked out for an entire day/out of it) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012H21B, 026L20A and 029K20A) for COVID-19 vaccination.     The patient's past medical history included Rheumatoid arthritis. Concomitant products included METHOTREXATE and FOLIC ACID for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (knocked out for an entire day/out of it). At the time of the report, FATIGUE (knocked out for an entire day/out of it) had resolved.            No Treatment medication were reported.   This case was linked to MOD-2022-637954, MOD-2022-638298 (Patient Link).
Pt was asked to sit for 15 minutes to observes, after about 5 minutes of sitting down pt walked to the cashier to get the drink and he passed out for about 30 seconds.
Started out as a severe nose bleed, pounding headache, fever and then shortness of breath. Went to urgent care clinic & MD stated that he has seen 3 other pts w/rxn to flu shot this year.
Pt reported feeling dizzy approximately 10 minutes after vaccination.  Pt reports that she feels dizzy after injections, and mother reports that pt has also felt dizzy with blood draws.  Pt's symptoms resolved after lying supine, and eating.
Extreme Tenderness in my ribs. It's hurts to bend or touch, lay down.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FH8030) via an unspecified route of administration in the left arm on 20Nov2021 at 17:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included acne and sulfa allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received paracetamol; oxycodone hydrochloride; oxycodone terephthalate (PERCOCET) and experienced drug allergy. On 21Nov2021 at 08:00, the patient experienced extreme tenderness in her ribs; it hurt to bend, touch or lay down. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme tenderness in ribs; it hurt to bend, touch or lay down was resolving at the time of this report.
I was congested when I woke up the day after the vaccination. I blew my nose and my mucous was tinged red with blood. My mucous returned to normal after a couple of hours of being awake. I have no history of nosebleeds and have no other explanation for the nose bleed except a possible vaccination side effect.
"My mom (84 years old, female) had her Pfizer booster vaccine; some arm pain; groggy; This is a spontaneous report from a contactable consumer or other non hcp. A 84-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 30Sep2021 (at the age of 84-years-old) as dose 3 (booster), single for COVID-19 immunization. The patient medical history was not reported. The patient concomitant medications were reported as none. The patient previously received bnt162b2 first dose of COVID-19 Vaccine (Manufacturer unknown) via an unspecified route of administration on an unspecified date as dose 1 single and received second dose of COVID-19 Vaccine (Manufacturer unknown) via an unspecified route of administration on an unspecified date as dose 1 single for COVID-19 immunization. On 30Sep2021, the patient had some arm pain; little bit of a sore arm but, she felt it more today but now it is going away. She had no diarrhea. She was groggy; she did feel sleepy after the COVID vaccine, like drunk sleepy, and she does feel sleepy now but, she is glad that she got it. On 01Oct2021, she had arm pain in the morning but, it was only when she touches it that she feels it. She did not bleed after having the COVID vaccine. The outcome of the event pain in extremity was recovering and unknown for other events.  No follow-up attempts were possible; information about lot/batch number cannot be obtained. No further information was expected.
In bed for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (In bed for 2 days) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040M20A) for COVID-19 vaccination.     The patient's past medical history included Headache, Accident (She was hit by a truck when she was 12 years old) in 1980 and Spondylodesis. Concurrent medical conditions included Breast cancer (Left breast) and Herpes NOS (Herpes breakout too all over in face and into oral cavity.).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BEDRIDDEN (In bed for 2 days). At the time of the report, BEDRIDDEN (In bed for 2 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was provided.  No treatment information was provided.  Patient received second dose of vaccine on 04-Mar-2021.   This case was linked to MOD-2021-293959 (Patient Link).
Patient positive for covid-19 11/26/2020. Vaccinated 12/22/2020 and 01/12/2021 with pfizer. Patient sent to hosptial on 06/19/2021 and tested positive for covid-19 06/20/2021 with symptoms. .
Herpes Zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 77 year old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 18-OCT-2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster. On an unspecified date, the patient was treated by a physician for herpes zoster. The outcome of herpes zoster was not reported. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).   Additional information has been requested.
Febrile since 5/13/03 (101), received DTaP #3, Hib #3, Prevnar #2 on 5/15/03. Temp to 105.5 5/16 PM.
raised rash on my entire legs and arms; allergic reaction; Elevated blood pressure; This case was reported by a consumer and described the occurrence of raised rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st December 2020, the patient received the 1st dose of Shingrix. On 2nd January 2021, 32 days after receiving Shingrix, the patient experienced raised rash. In January 2021, the patient experienced allergic reaction and blood pressure high. On an unknown date, the outcome of the raised rash, allergic reaction and blood pressure high were unknown.   It was unknown if the reporter considered the raised rash, allergic reaction and blood pressure high to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient. The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per vaccine indication. The patient broke out with a raised rash on my entire legs and arms but no rash on my torso, face, feet, or hands. The patient did not had have fever, elevated blood pressure, no signs of an infection. The patient seek medical attention prior week to the report and blood and urine labs were drawn and all metabolic function is was normal. The patient inquired Is was it possible to had a very delayed allergic reaction and was concerned about taking the booster. The reporter had taken photo graphs which may help. The reporter consented to follow via mobile phone.
6 HOURS POST GETTING VACCINE - DEVELOPED HIGH FEVER, CHILLS AND BODY ACHES.
Approximately 5 minutes after receiving the pfizer vaccination the patient approached the pharmacy stating he didn't feel well. He appeared pallid and diaphoretic.   Patient was asked to sit down while pharmacist applied an ice pack to patient's neck.  Patient proceeded to vomit 3 times after which he immediately felt better. Diaphoresis and pallor resolved as well
mild headache; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 09Mar2021 at 14:45 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included chemotherapy, anal cancer and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any medication within two weeks of vaccination. On 10Mar2021 at 02:00, the patient experienced mild headache and body aches. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mild headache and body aches was resolved on 10Mar2021 at 14:00.   No follow-up attempts are needed. No further information is expected.
Within a few minutes of his 2nd dose, he said his throat felt tight like it was closing. I alerted staff. They checked his blood pressure. 155/50. Made us wait another 20 minutes and my dad said he felt better after drinking water. Once we got home he said he felt brain fog and a bit dizzy. He passed away on May 4th, 2021. 3 days after his 2nd dose of Pfizer. It was ruled a heart attack.
I tested positive for COVID-19 on 3/10/2023. I had a sore throat, fever, runny nose, and congestion. I contacted the doctor, but she would not prescribe PAXLOVID because she said I had COVID-19 too long to get the medication. She did prescribe amoxicillin and was going to prescribe a cough medication with codeine, but I can't take codeine. I just took ROBITUSSIN. I am feeling better but still have congestion.
Severe vomiting and diarrhea lasted 12 hrs. Passed out on floor.